Application
PRAM1 antibody [C3], C-term detects PRAM1 protein at nucleus on human colon carcinoma by immunohistochemical analysis. Sample: Paraffin-embedded colon carcinoma. PRAM1 antibody [C3], C-term dilution: 1:500.Application
Sample(30 μg of whole cell lysate) A:293T 7.5% SDS PAGE diluted at 1:1000| Product Name | PRAM1 antibody , C-term |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit Polyclonal antibody to PRAM1 (PML-RARA regulated adaptor molecule 1)The protein encoded by this gene is similar to FYN binding protein (FYB/SLAP-130), an adaptor protein involved in T cell receptor mediated signaling. This gene is expressed and regulated during normal myelopoiesis. The expression of this gene is induced by retinoic acid and is inhibited by the expression of PML-RARalpha, a fusion protein of promyelocytic leukemia (PML) and the retinoic acid receptor-alpha (RARalpha). [provided by RefSeq] |
| Immunogen | Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human PRAM1. The exact sequence is proprietary. |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | IHC-PWB |
| *Optimal dilutions/concentrations should be determined by the researcher.
: |
|
| Species Reactivity | Human |
| Concentration | 0.5mg/ml |
| Purification | Affinity purified |
| Gene Synonyms | MGC39864 antibody PML-RAR antibody PRAM-1 antibody PRAM1 antibody PML-RARA-regulated adapter molecule 1 antibody PRAM antibody PML-RARA target gene encoding an Adaptor Molecule-1 antibody PML-RARA regulated adaptor molecule 1 antibody |
|---|---|
| Molecular Weight(MW) | 79 kDa (note) |
Application
PRAM1 antibody [C3], C-term detects PRAM1 protein at nucleus on human colon carcinoma by immunohistochemical analysis. Sample: Paraffin-embedded colon carcinoma. PRAM1 antibody [C3], C-term dilution: 1:500.
Application
Sample(30 μg of whole cell lysate) A:293T 7.5% SDS PAGE diluted at 1:1000| Positive Control | 293T |
|---|---|
| Application Notes | *Optimal dilutions/concentrations should be determined by the researcher.
: |
| Form | Liquid |
|---|---|
| Storage Instructions | Keep as concentrated solution. Aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | 0.1M Tris, 0.1M Glycine, 10% Glycerol (pH7). 0.01% Thimerosal was added as a preservative. |
